[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-339294-en":59,"doc-seo-339294-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":72,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":73,"language":74,"language_code":75,"site_id":76,"html_lang":75,"table_of_contents":77,"faqs":78,"seo_title":79,"seo_description":66,"update_tm":80,"read_time":41,"preview_page_count":19,"preview_urls":81},339294,4810365810221,"Aurora","https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Psychological outcomes in patients with rare cancers - a systematic review and meta-analysis","A PRISMA-adherent systematic review and meta-analysis synthesized English-language studies published since 2000 to 30 January 2024 to quantify depression, anxiety, suicide, and PTSD among patients with rare cancers. Thirty-two studies comprising 57,470 patients were included. Rare-cancer patients showed significantly higher risks of depression and anxiety versus healthy controls, and elevated suicide incidence and PTSD prevalence versus common cancer types. Advanced disease, chemotherapy, lower income, and lower social status emerged as key risk factors, supporting early psychological screening and targeted intervention research.","Articles   \nPsychological outcomes in patients with rare cancers: a systematic review and meta-analysis  \nChen Ee Low,a Sean Loke,a Ga Eun Pang,a Ben Sim,a and Valerie Shiwen Yangb,c,d, ∗  \naYong Loo Lin School of Medicine, National University of Singapore, 10 Medical Dr, Singapore, 117597, Singapore  \nbDivision of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Crescent, Singapore, 169610, Singapore cTranslational Precision Oncology Lab, Institute of Molecular and Cell Biology (IMCB), A*STAR, 61 Biopolis Dr, Proteos, Singapore, 138673, Singapore  \ndOncology Academic Clinical Program, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore  \nSummary  \nBackground Rare cancers are those that exhibit an incidence of less than six per 100,000 in a year. On average, the ﬁveyear relative survival for patients with rare cancers is worse than those with common cancers. The traumatic experience of cancer can be further intensiﬁed in patients with rare cancers due to the limited clinical evidence and the lack of empirical evidence for informed decision-making. With rare cancers cumulatively accounting for up to 25% of all cancers, coupled with the rising burden of rare cancers on societies globally, it is necessary to determine the psychological outcomes of patients with rare cancers.  \nMethods This PRISMA-adherent systematic review (PROSPERO: CRD42023475748) involved a systematic search of PubMed, Embase, Cochrane and PsycINFO for all peer-reviewed English language studies published since 2000 to 30th January 2024 that evaluated the prevalence, incidence and risk of depression, anxiety, suicide, and post-traumatic stress disorder (PTSD) in patients with rare cancers. Two independent reviewers appraised and extracted the summary data from published studies. Random effects meta-analyses and meta-regression were used for primary analysis.  \nFindings We included 32 studies with 57,470 patients with rare cancers. Meta-analyses indicated a statistically signiﬁcant increased risk-ratio (RR) of depression (RR = 2.61, 95% CI: 1.43–4.77, I2 = 97%) and anxiety (RR = 2.66, 95% CI: 1.27–5.55, I2 = 92%) in patients with rare cancers compared to healthy controls. Weidentiﬁed a high suicide incidence (315 per 100,000 person-years, 95% CI: 162–609, I2 = 95%), prevalence of depression (17%, 95% CI: 14–22, I2 = 88%), anxiety (20%, 95% CI: 15–25, I2 = 96%) and PTSD (18%, 95% CI: 9–32, I2 = 25%) . When compared to patients with common cancer types, suicide incidence, and PTSD prevalence were signiﬁcantly higher in patients with rare cancers. Systematic review found that having advanced disease, chemotherapy treatment, lower income, and social status were risk factors for negative psychological outcomes.  \nInterpretation We highlight the need for early identiﬁcation of psychological maladjustment in patients with rare cancers. Additionally, studies to identify effective interventions are imperative.  \nFunding This study was supported by the National Medical Research Council Transition Award, SingHealth DukeNUS Oncology Academic Clinical Programme, the Khoo Pilot Collaborative Award, the National Medical Research Council Clinician Scientist-Individual Research Grant-New Investigator Grant, the Terry Fox Grant and the Khoo Bridge Funding Award.  \nCopyright © 2024 The Author(s) . Published by Elsevier Ltd. This is an open access article under the CC BY-NC license ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)).  \nKeywords: Rare; Neoplasms; Sarcoma; Mental health; Psychology  \nIntroduction  \nAccording to the Surveillance of Rare Cancers in Europe (RARECARE) deﬁnition, rare cancers exhibit an incidence of less than six per 100,000 in a year.1 Despite the  \nindividual rarity of each entity, as a whole these cancers affect about one in four cancer patients.2 On average, the ﬁve-year relative survival for rare cancers is worse than that for common cancers.1 It is widely recognised that","cbCairWlfYbi1EZd","https://ap.wps.com/l/cbCairWlfYbi1EZd","pdf",1389450,11,12,"English","en",105,"# Summary\n## Background\n## Methods\n## Findings\n## Interpretation\n## Funding\n# Research in context\n## Evidence before this study\n## Added value of this study\n## Implications of all the available evidence","[{\"question\":\"Which psychological outcomes were assessed for patients with rare cancers in this study?\",\"answer\":\"Depression, anxiety, suicide, and post-traumatic stress disorder (PTSD).\"},{\"question\":\"What were the main comparisons and key results versus healthy controls?\",\"answer\":\"Advanced disease, chemotherapy treatment, lower income, and lower social status were identified as risk factors for negative psychological outcomes.\"},{\"question\":\"What does the study recommend based on its findings?\",\"answer\":\"It highlights the need for early identification of psychological maladjustment and emphasizes the imperative to study effective interventions.\"}]","Psychological outcomes in patients with rare cancers - a systematic review and meta-analysis | PDF",1790029311,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de5d8f9e924a016911c5312daf86d04b.webp",983,1310,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/411d3837256254fe02d6fecfb8768f81.webp",982,1309,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ecf5590b4c675fab1c55f3ec0546778.webp",981,1308,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a1ab2383b88039570690dcc501ba5c5.webp",980,1306,{"code":4,"msg":100,"data":101},"ok",{"site_id":76,"language":75,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"psychological-outcomes-in-patients-with-rare-cancers-a-systematic-review-and-meta-analysis","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/psychological-outcomes-in-patients-with-rare-cancers-a-systematic-review-and-meta-analysis/339294/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":75,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/psychological-outcomes-in-patients-with-rare-cancers-a-systematic-review-and-meta-analysis/339294.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":136,"interactionType":137,"userInteractionCount":72},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"Which psychological outcomes were assessed for patients with rare cancers in this study?","Question",{"text":146,"@type":147},"Depression, anxiety, suicide, and post-traumatic stress disorder (PTSD).","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"What were the main comparisons and key results versus healthy controls?",{"text":151,"@type":147},"Advanced disease, chemotherapy treatment, lower income, and lower social status were identified as risk factors for negative psychological outcomes.",{"name":153,"@type":144,"acceptedAnswer":154},"What does the study recommend based on its findings?",{"text":155,"@type":147},"It highlights the need for early identification of psychological maladjustment and emphasizes the imperative to study effective interventions.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":76},1790388190]